Bioluminescent imaging demonstrates that transplanted human embryonic stem cell-derived CD34+ cells preferentially develop into endothelial cells

Xinghui Tian, Melinda K. Hexum, Vesselin R. Penchev, Russell J. Taylor, Leonard D. Shultz, Dan S. Kaufman

Research output: Contribution to journalArticlepeer-review

41 Scopus citations

Abstract

Human embryonic stem cells (hESCs) provide an important resource for novel regenerative medicine therapies and have been used to derive diverse cell populations, including hematopoietic and endothelial cells. However, it remains a challenge to achieve significant engraftment of hESC-derived blood cells when transplanted into animal models. To better understand mechanisms that enhance or limit the in vivo developmental potential of hESC-derived cells, we utilized hESCs that express firefly luciferase (luc) to allow noninvasive, real-time bioluminescent imaging of hESC-derived CD34+ cells transplanted into the liver of neonatal immunodeficient mice. Serial imaging demonstrated stable engraftment and expansion of the luc+ hESC-derived cells in vivo over several months. While we found that these hESC-derived CD34+ cells have bipotential ability to generate both hematopoietic and endothelial lineages in vitro, these studies demonstrate preferential differentiation into endothelial cells in vivo, with only low levels of hematopoietic cell engraftment. Therefore, these studies reveal key differences in the developmental potential of hESC-derived cells using in vitro and in vivo analyses. Although transplanted hESC-derived CD34+ cells are well-suited for revascularization therapies, additional measures are needed to provide higher levels of long-term hematopoietic engraftment.

Original languageEnglish (US)
Pages (from-to)2675-2685
Number of pages11
JournalSTEM CELLS
Volume27
Issue number11
DOIs
StatePublished - Nov 2009

Keywords

  • Bioluminescent imaging
  • Endothelial cells
  • Hematopoietic cells
  • Human embryonic stem cells

Fingerprint Dive into the research topics of 'Bioluminescent imaging demonstrates that transplanted human embryonic stem cell-derived CD34<sup>+</sup> cells preferentially develop into endothelial cells'. Together they form a unique fingerprint.

Cite this